Research Confirms Tests to Diagnose Bacterial Vaginosis Work
Molecular tests provide a precise and safe diagnosis for bacterial vaginosis, or vaginitis, as it is sometimes called. In a study that has now been published in the international Journal of Women's Health and Gynecology, professor of obstetrics and gynecology Per-Göran Larsson draws this conclusion based on a comprehensive clinical study.
His research shows that molecular DNA tests, which determine both the quantity of bacteria and the relationship between them, provide a 94 percent safe diagnosis for bacterial vaginosis, which is significantly higher than the number of safe diagnoses made in primary care. The background to the study, conducted with 300 women in a Swedish hospital between 2012 and 2013, was the need for a more objective and reliable way to test for the infection, which is the most common cause of troublesome and foul-smelling discharge in women of childbearing age.
- Dynamic Code's self-test for bacterial vaginosis could revolutionise women's health. "I can now say this with certainty; after validating the test in my research, I have been able to show that it works," he continues.
Today, different methods of treatment for bacterial diagnosis are discussed, but provision of the correct treatment requires, first and foremost, the correct diagnosis. Today, healthcare providers use the so-called Amsels method of diagnosis, where three out of four criteria are required to ensure a diagnosis: the nature of the discharge, sniff test, pH measurement and microscopy. However, the woman typically is not tested for all the criteria during doctor's appointments. The main criterion, examination under a microscope, is largely never carried out. Previous studies in the field have shown that the statistics for incorrect diagnoses for vaginal complications are high.
- "Bacterial vaginosis is a low priority disease and too many women testify that they are sent home from the health centre, without all four criteria for diagnosis being investigated", says Per-Göran Larsson.
- "Our molecular test for bacterial vaginosis and vaginitis allows women to test themselves at home, and then obtain an accurate diagnosis and treatment directly through digital healthcare providers. You no longer have to suffer for years, take the wrong medicine unnecessarily, or take medication that exacerbates the problem in the long run. It is also important to get a correct diagnosis immediately, as the problems could be caused by something else", says Anne Kihlgren, founder and CEO of Dynamic Code.
For more information, please contact:
Per-Göran Larsson, Associate Professor and Consultant in Obstetrics and Gynecology and Medical Expert at Dynamic Code
+46 (0)70 245 98 20
Anne Kihlgren, Founder and CEO Dynamic Code
+46 (0) 070 819 16 21
You can read more here about Dynamic Code's test for bacterial vaginosis.
You can read more here about the study in the Journal of Women's Health and Gynecology.